PULSE

RVMD +0.8% 190.27PPBT +13.9% 1.09IMRX +0.8% 4.02ELTX -5.4% 1.75ACTU -3.2% 0.37RNXT +4.6% 1.49TOVX -1.5% 0.19NVCR -7.5% 13.11RCUS +1.2% 18.61VSTM -1.8% 9.66CADL -0.2% 8.65ONCY -3.1% 0.43CRDF +1.6% 0.91BNTX +1.3% 89.13AZN +2.9% 174.40MRK +3.8% 146.33IPSEY -1.4% 42.01BMY +1.4% 61.39DRTS -0.9% 13.23

DELAYED 15 MIN

The PulseLive from the wires

Every move in pancreatic cancer research.
One board.

Trial readouts, detection breakthroughs, funding moves — and the public companies doing the work. Knowledge, not investment advice.

Aggregated from PubMed, ClinicalTrials.gov, company filings and health wires — always linked to the source. Quotes delayed 15 min. Informational only, not investment advice.

PULSE

RVMD +0.8%PPBT +13.9%IMRX +0.8%ELTX -5.4%ACTU -3.2%RNXT +4.6%TOVX -1.5%NVCR -7.5%RCUS +1.2%VSTM -1.8%CADL -0.2%ONCY -3.1%CRDF +1.6%BNTX +1.3%AZN +2.9%MRK +3.8%IPSEY -1.4%BMY +1.4%DRTS -0.9%

The PulseLive from the wires

Every move in pancreatic cancer research. One board.

Trial readouts, detection breakthroughs, funding moves — and the public companies doing the work. Knowledge, not investment advice.

Aggregated from PubMed, ClinicalTrials.gov, company filings and health wires — always linked to the source. Quotes delayed 15 min. Informational only, not investment advice.

Every move in pancreatic cancer research.One board.

Every move in pancreatic cancer research. One board.

Every move in pancreatic cancer research.
One board.